Page 16 - Service Testing News Today

Cytokinetics' stock rocketed Wednesday, after the cardiovascular-biopharmaceutical company announced positive results from a Phase 3 trial of aficamten, a...

By Will Feuer AlloVir, a clinical-stage cell-therapy company, said it has halted three of its late-stage clinical trials following recommendations from...

By Adria Calatayud Sanofi said it would end a clinical-development program for its tusamitamab ravtansine drug candidate after a late-stage trial in...

By Denny Jacob Immunovant shares rose 9.6% to $39.64 following positive data from a trial on its batoclimab treatment for Graves' disease, an immune system...

French pharmaceuticals giant Sanofi on Thursday said it would be halting development of a promising cancer treatment after the cutting-edge candidate failed...

By Denny Jacob Passage Bio shares were 29% higher at 98 cents in premarket trading following initial safety and biomarket data from patients in a clinical...

By Chris Wack Tonix Pharmaceuticals said a Phase 3 study evaluating TNX-102 SL cyclobenzaprine HCl sublingual tablets met its pre-specified primary endpoint...

By Sabela Ojea Immunovant said it received positive data from its ongoing 24-week Phase 2 clinical trial for its batoclimab treatment for Graves' disease....

By Denny Jacob Aldeyra Therapeutics shares rose 12% to $3.31 following news of positive topline results from a Phase 2 clinical trial of ADX-629, a treatment...

By Adriano Marchese Mirum Pharmaceuticals said Monday that data from a Phase 2 trial for its potential biliary atresia treatment Livmarli didn't meet either...